ReviewNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2020
Management of COVID-19 in people with epilepsy: drug considerations.
Review in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 4 syntheses or guidelines pooled it, 54 citations in OpenAlex.
- Epilepsy and the risk of severe coronavirus disease 2019 outcomes: A systematic review, meta-analysis, and meta-regression.Epilepsy & behavior : E&B · 2021Pooled it
- COVID-19, de novo seizures, and epilepsy: a systematic review.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2021Pooled it
- Pharmacological management of seizures in patients with COVID-19: a systematic review.AAS open research · 2021Pooled it
- Toxicity of psychotropic drugs in patients with COVID-19: A systematic review.General hospital psychiatryPooled it
- Global, regional and national burden of epilepsy in children and adolescents, 1990-2021: A systematic analysis for the Global Burden of Disease Study 2021.European journal of clinical investigation · 2026Article
- Alterations in Seizure Frequency in Patients with Epilepsy Following Coronavirus Disease 2019.Journal of epilepsy research · 2023Article
- The occurrence of emerging compounds in real urban wastewater before and after the COVID-19 pandemic in Cali, Colombia.Current opinion in environmental science & health · 2023Review
- Potential risk of liver injury in epileptic patients during COVID-19 pandemic.World journal of virology · 2022Review
- Review
- Depression and sexual functions in epilepsy patients: Comparison before and during the COVID-19 pandemic.Annales medico-psychologiques · 2022Article
- Effects of the COVID-19 pandemic on medication adherence: In the case of antiseizure medications, A scoping review.Seizure · 2021Article
- Drug Interactions for Patients with Respiratory Diseases Receiving COVID-19 Emerged Treatments.International journal of environmental research and public health · 2021Review
- COVID-19 in Children with Down Syndrome: Data from the Trisomy 21 Research Society Survey.Journal of clinical medicine · 2021Article
- Pharmacokinetic Drug-Drug Interactions among Antiepileptic Drugs, Including CBD, Drugs Used to Treat COVID-19 and Nutrients.International journal of molecular sciences · 2021Review
- Covid-19 decompensating epilepsy in the elderly: A case report.Annals of medicine and surgery (2012) · 2021Article
- Influence of COVID-19 pandemic on quality of life in patients with epilepsy - Follow-up study.Epilepsy & behavior : E&B · 2021Article
- Neurologic Emergencies during the Coronavirus Disease 2019 Pandemic.Neurologic clinics · 2021Review
- Neurological Complications of COVID-19: Underlying Mechanisms and Management.International journal of molecular sciences · 2021Review
- Responses of people with epilepsy to the COVID-19 pandemic in the time of national lockdown.Epilepsy & behavior : E&B · 2021Article
- Epilepsy and COVID-19: Updated evidence and narrative review.Epilepsy & behavior : E&B · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
People with epilepsy (PWE) are neither more likely to be infected by the coronavirus nor are they more likely to have severe COVID-19 manifestations because they suffer from epilepsy. However, management of COVID-19 in PWE may be more complicated than that in other individuals. Drug-drug interactions could pose significant challenges and cardiac, hepatic, or renal problems, which may happen in patients with severe COVID-19, may require adjustment to antiepileptic drugs (AEDs). In this review, we first summarize the potential drug-drug interactions between AEDs and drugs currently used in the management of COVID-19. We then summarize other challenging issues that may happen in PWE, who have COVID-19 and are receiving treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.